MENU
QURE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

uniQure (QURE) Ownership - Who owns uniQure?

uniQure NV is a gene therapy company... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.22B
P/E Ratio
N/A
Total Cash
694.25M
Projected Growth
N/A
Total Debt
66.16M
Revenue
15.75M
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash/Share
11.15
Total Debt/Equity
N/A
Revenue/Share
0.29 USD as % of share price

Fundamentals

QURE
Capitalization
1.22B
P/E Ratio
N/A
Risk (Beta)
0.39
Dividend Yield
N/A
Total Cash
694M
Total Cash/Share
11.15
Total Debt
66.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.29%
Revenue
15.8M
ROE
N/A
Book Value
229M
P/B Ratio
5.31
Cash Flow
N/A
Earnings
-4.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.68M
Current Ratio
7.12
Current Revenue Per Employee
17708.13
Dividends Per Share - Security
N/A
EBITDA
-146.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
89.25
Revenue To Assets
-30.65
Shares Held By Institutions
4.65B
Shares Outstanding - Current
62.3M
Total Liabilities
660M
Total Volume MTD
N/A
Value
N/A
Gain YTD
11.835
View a ticker or compare two or three
QURE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. QURE showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company which engages in the discovery, development, and commercialization of gene therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com